These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 24730063

  • 1. Towards selective inhibition of histone deacetylase isoforms: what has been achieved, where we are and what will be next.
    Thaler F, Mercurio C.
    ChemMedChem; 2014 Mar; 9(3):523-6. PubMed ID: 24730063
    [Abstract] [Full Text] [Related]

  • 2. The discovery of colchicine-SAHA hybrids as a new class of antitumor agents.
    Zhang X, Zhang J, Tong L, Luo Y, Su M, Zang Y, Li J, Lu W, Chen Y.
    Bioorg Med Chem; 2013 Jun 01; 21(11):3240-4. PubMed ID: 23602523
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and biochemical analysis of 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoro-N-hydroxy-octanediamides as inhibitors of human histone deacetylases.
    Henkes LM, Haus P, Jäger F, Ludwig J, Meyer-Almes FJ.
    Bioorg Med Chem; 2012 Jan 15; 20(2):985-95. PubMed ID: 22182579
    [Abstract] [Full Text] [Related]

  • 4. Current trends in the development of histone deacetylase inhibitors: a review of recent patent applications.
    Thaler F.
    Pharm Pat Anal; 2012 Mar 15; 1(1):75-90. PubMed ID: 24236715
    [Abstract] [Full Text] [Related]

  • 5. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT, Knoff JR, Pflum MKH.
    Eur J Med Chem; 2018 Jan 01; 143():1790-1806. PubMed ID: 29150330
    [Abstract] [Full Text] [Related]

  • 6. Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif.
    Wagner FF, Olson DE, Gale JP, Kaya T, Weïwer M, Aidoud N, Thomas M, Davoine EL, Lemercier BC, Zhang YL, Holson EB.
    J Med Chem; 2013 Feb 28; 56(4):1772-6. PubMed ID: 23368884
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors.
    Huang WJ, Chen CC, Chao SW, Yu CC, Yang CY, Guh JH, Lin YC, Kuo CI, Yang P, Chang CI.
    Eur J Med Chem; 2011 Sep 28; 46(9):4042-9. PubMed ID: 21712146
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.
    Pabba C, Gregg BT, Kitchen DB, Chen ZJ, Judkins A.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):324-8. PubMed ID: 21109435
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.
    Guan P, Sun F, Hou X, Wang F, Yi F, Xu W, Fang H.
    Bioorg Med Chem; 2012 Jun 15; 20(12):3865-72. PubMed ID: 22579621
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and preliminary bioactivity studies of 1,2-dihydrobenzo[d]isothiazol-3-one-1,1-dioxide hydroxamic acid derivatives as novel histone deacetylase inhibitors.
    Han L, Wang L, Hou X, Fu H, Song W, Tang W, Fang H.
    Bioorg Med Chem; 2014 Mar 01; 22(5):1529-38. PubMed ID: 24525003
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and Investigation of Therapeutic Potential of Isoform-Specific HDAC8 Inhibitors for the Treatment of Cutaneous T Cell Lymphoma.
    Umamaheswari A, Puratchikody A, Hari N.
    Anticancer Agents Med Chem; 2019 Mar 01; 19(7):916-934. PubMed ID: 30836926
    [Abstract] [Full Text] [Related]

  • 15. Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors.
    Tashima T, Murata H, Kodama H.
    Bioorg Med Chem; 2014 Jul 15; 22(14):3720-31. PubMed ID: 24864038
    [Abstract] [Full Text] [Related]

  • 16. Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket.
    Tabackman AA, Frankson R, Marsan ES, Perry K, Cole KE.
    J Struct Biol; 2016 Sep 15; 195(3):373-378. PubMed ID: 27374062
    [Abstract] [Full Text] [Related]

  • 17. Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid.
    Bieliauskas AV, Weerasinghe SV, Negmeldin AT, Pflum MK.
    Arch Pharm (Weinheim); 2016 May 15; 349(5):373-82. PubMed ID: 27062198
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors.
    De Vreese R, D'hooghe M.
    Eur J Med Chem; 2017 Jul 28; 135():174-195. PubMed ID: 28453994
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of N-hydroxycinnamides capped with a naturally occurring moiety as inhibitors of histone deacetylase.
    Huang WJ, Chen CC, Chao SW, Lee SS, Hsu FL, Lu YL, Hung MF, Chang CI.
    ChemMedChem; 2010 Apr 06; 5(4):598-607. PubMed ID: 20209563
    [Abstract] [Full Text] [Related]

  • 20. New aryldithiolethione derivatives as potent histone deacetylase inhibitors.
    Tazzari V, Cappelletti G, Casagrande M, Perrino E, Renzi L, Del Soldato P, Sparatore A.
    Bioorg Med Chem; 2010 Jun 15; 18(12):4187-94. PubMed ID: 20576572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.